Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02688530 · ClinicalTrials.gov registry record · Phase 4
Intravenous Dexamethasone on Supraclavicular Brachial Plexus Block for Shoulder Arthroscopy
A Phase 4 study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 140
- Enrollment target
NCT02688530 is a Phase 4 study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 140 participants.
The verdict
NCT02688530, a Phase 4 study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 140 participants
- Enrollment target
Study Summary
Previous studies have confirmed that IV dexamethasone prolongs brachial plexus blocks. However, these studies only used fixed doses of IV dexamethasone at relatively high doses, which could potentially lead to increased glucose levels, delayed wound healing, and unintended side effects. There remains a paucity of research on the effective dose range of IV dexamethasone for the prolongation of supraclavicular blocks. The optimal dosage of IV dexamethasone for prolongation of analgesia vs. motor block prolongation from supraclavicular blocks in shoulder surgery has yet to be delineated.
Interventions
- DRUG IV Saline
- DRUG IV Dexamethasone 4mg
- DRUG IV Dexamethasone 6mg
- DRUG IV Dexamethasone 8mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-11-19 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02688530
The ClinicalTrials.gov registry entry for NCT02688530 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which IV Saline is the first listed.
NCT02688530 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02688530 about?
NCT02688530 is a clinical study titled "Intravenous Dexamethasone on Supraclavicular Brachial Plexus Block for Shoulder Arthroscopy". Previous studies have confirmed that IV dexamethasone prolongs brachial plexus blocks. However, these studies only used fixed doses of IV dexamethasone at relatively high doses, which could potentially lead to increased glucose levels, delayed wound healing, and unintended side effects. There remain...
What is the current status of trial NCT02688530?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 140 participants. The study started on 2016-05. Estimated completion is 2017-11-19.
What interventions are being tested in trial NCT02688530?
The interventions under investigation include: IV Saline (DRUG), IV Dexamethasone 4mg (DRUG), IV Dexamethasone 6mg (DRUG), IV Dexamethasone 8mg (DRUG).
Who is sponsoring clinical trial NCT02688530?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.